Media-OutReach Newswire UMP Healthcare Innov Centre signs MoU with Israel Export and International Cooperation Institute
Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Cushman & Wakefield: Hong Kong Retail Market in Gradual 1H Recovery Since Border Reopening, Office Leasing Market Yet to Stage Significant Rebound
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection